Evidence map›Paper›PMID 27789990›Full record

ReviewOpen access rheumatology : research and reviews2009

Rheumatoid arthritis: Disease or syndrome?

Jessica A Stanich, John D Carter, Judith Whittum-Hudson, Alan P Hudson

Open access · goldAbstract readReview
In one paragraph

Review in Open access rheumatology : research and reviews, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Frontiers in aging neuroscience · 2018
    Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jessica A StanichDepartment of Immunology and Microbiology, Wayne State University School of Medicine, Detroit, MI, USA.
John D CarterDivision of Rheumatology, Department of Internal Medicine, University of South Florida School of Medicine, Tampa, FL, USA.
Judith Whittum-HudsonDepartment of Immunology and Microbiology, Wayne State University School of Medicine, Detroit, MI, USA.
Alan P HudsonDepartment of Immunology and Microbiology, Wayne State University School of Medicine, Detroit, MI, USA.
Wayne State University · US

Funding

REITERS SYNDROME--MECHANISM OF CHLAMYDIA PATHOGENESISR01AR042541 · NIAMS · WAYNE STATE UNIVERSITY · PI HUDSON, ALAN PAUL · 1993 to 2008
$2.6M
Pathogenic mechanisms in chlamydial reactive arthritisR01AR048331 · NIAMS · WAYNE STATE UNIVERSITY · PI WHITTUM-HUDSON, JUDITH A · 2001 to 2005
$1.5M
Combination Antibotics as a Treatment for Chlamydia-Induced Reactive ArthritisR21AR053646 · NIAMS · UNIVERSITY OF SOUTH FLORIDA · PI CARTER, JOHN DILLON · 2006 to 2007
$366k
NIAMS NIH HHS R01 AR042541NIAMS NIH HHS R01 AR048331NIAMS NIH HHS R21 AR053646
6 · The paper itself

Abstract

Rheumatoid arthritis (RA) has been described in the medical literature for over two hundred years, but its etiology remains unknown. RA displays phenotypic heterogeneity, and it is a relatively prevalent clinical entity: it affects approximately 1% of the population, resulting in enormous pathologic sequelae. Earlier studies targeting the cause(s) of RA suggested potential infectious involvement, whereas more recent reports have focused on a genetic origin of the disease. However, neither infection nor genetics, nor any other single factor is currently accepted as causative of RA. In this article we review studies relating to the etiology of RA, and those of several related matters, and we conclude that the literature indeed does provide insight into the causes underlying the initiation of RA pathogenesis. Briefly, given the remarkable phenotypic variation of RA, especially in its early stages, as well as a number of other characteristics of the condition, we contend that RA is not a discrete clinical entity with a single etiological source. Rather, we argue that it represents a common clinical endpoint for various starting points, each of which is largely guided by as yet poorly understood aspects of the genetic background of the affected individual. Adoption of this alternative view of the origin of RA will have significant consequences for future research and for development of new therapeutic interventions for this burdensome condition.

Indexed as

rheumatoid arthritis pathogenesis etiologic studies genetic background

Identifiers

PMID27789990
PMCPMC5074722
OpenAlexW2051633726

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.